Search Results for: Breyanzi
April CGT
Looking Back at the Cell and Gene Therapy Leaders That Made Waves in 2024
2025-03-31
ASGCT 2024 ASGCT Previews
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Trials & Approvals Clinical TrialCancer
Bristol Myers Squibb Provides an Update on Kidney Cancer Treatment
2022-08-01
Special Gene and Cell Therapy
Gene & Cell Therapy’s Big Leaps in the Past 5 Years
2022-07-08
In-Depth FDA
Roe Reversal May Cause Downstream Issues in Repurposing Mifepristone
2022-06-27
Trials & Approvals B-cell Lymphoma
Bristol Myers’ Breyanzi Now FDA-Approved for Earlier Lymphoma
2022-06-27
Trials & Approvals CAR T-cell Therapy
Novartis CAR-T Cell Therapy Receives FDA Approval for Third Indication to Treat Follicular Lymphoma
2022-05-30
Ranking & Reports FDA Approval
Market Insight on FDA-approvals: Rise of First-in-class and Regenerative Innovations
2022-03-17
Trials & Approvals Bristol Myers Squibb
Bristol-Myers Squibb’s Abecma Becomes First Approved CAR T-Cell Therapy for Multiple Myeloma in Japan
2022-01-24
Asia-Pacific CAR T-cell TherapyB-cell Lymphoma
Daiichi Sankyo Authorizes First Yescarta Treatment Site in Japan
2021-12-17
Trials & Approvals CAR T-cell Therapy
FDA Approves Kite’s CAR-T Therapy for Adult Leukemia
2021-10-04
Trials & Approvals
Roche Aspires for Dominance in DLBCL Market, Unveils Pivotal Trial Data for Polivy
2021-08-09
R&D
Gilead’s CAR-T Drug Outperforms Standard of Care in B-Cell Lymphoma Trial
2021-06-29
Gilead’s Yescarta Becomes First CAR-T Therapy to Score Regulatory Approval in China
2021-06-27
China’s Legend Biotech to Build a CAR-T Therapy Production Site in Belgium
2021-06-24
1 2
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2025 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top